According to Verve Therapeutics's latest financial reports the company's current earnings are A$24.39 Million. In 2023 the company made an earning of -A$0.36 Billion a decrease over its 2022 earnings that were of -A$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -A$0.34 Billion | -4.23% |
2023 | -A$0.36 Billion | 34.67% |
2022 | -A$0.27 Billion | 90.3% |
2021 | -A$0.14 Billion | 114.31% |
2020 | -A$64 Million |